Evidence map›Paper›PMID 33672379›Full record

ArticleBiomolecules2021

FITC-Dextran Release from Cell-Embedded Fibrin Hydrogels.

Viki Raz Lepsky, Sari Natan, Oren Tchaicheeyan, Avraham Kolel, Merav Zussman, Meital Zilberman, Ayelet Lesman

Abstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Acoustically responsive scaffolds: Unraveling release kinetics and mechanisms for sustained, steady drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  5. Bioactive Endodontic Hydrogels: From Parameters to Personalized Medicine.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Viki Raz LepskyDepartment of Materials Science and Engineering, Tel-Aviv University, Tel-Aviv, 55 Chaim Levanon St., Ramat Aviv 69978, Israel.
Sari NatanSchool of Mechanical Engineering, Faculty of Engineering, Tel-Aviv University, Tel-Aviv, 55 Chaim Levanon St., Ramat Aviv 69978, Israel.
Oren TchaicheeyanSchool of Mechanical Engineering, Faculty of Engineering, Tel-Aviv University, Tel-Aviv, 55 Chaim Levanon St., Ramat Aviv 69978, Israel.
Avraham KolelDepartment of Biomedical Engineering, Tel-Aviv University, Tel-Aviv, 55 Chaim Levanon St., Ramat Aviv 69978, Israel.ORCID 0000-0003-0626-4093
Merav ZussmanDepartment of Materials Science and Engineering, Tel-Aviv University, Tel-Aviv, 55 Chaim Levanon St., Ramat Aviv 69978, Israel.
Meital ZilbermanDepartment of Materials Science and Engineering, Tel-Aviv University, Tel-Aviv, 55 Chaim Levanon St., Ramat Aviv 69978, Israel.
Ayelet LesmanSchool of Mechanical Engineering, Faculty of Engineering, Tel-Aviv University, Tel-Aviv, 55 Chaim Levanon St., Ramat Aviv 69978, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrin hydrogel is a central biological material in tissue engineering and drug delivery applications. As such, fibrin is typically combined with cells and biomolecules targeted to the regenerated tissue. Previous studies have analyzed the release of different molecules from fibrin hydrogels; however, the effect of embedded cells on the release profile has yet to be quantitatively explored. This study focused on the release of Fluorescein isothiocyanate (FITC)-dextran (FD) 250 kDa from fibrin hydrogels, populated with different concentrations of fibroblast or endothelial cells, during a 48-h observation period. The addition of cells to fibrin gels decreased the overall release by a small percentage (by 7-15% for fibroblasts and 6-8% for endothelial cells) relative to acellular gels. The release profile was shown to be modulated by various cellular activities, including gel degradation and physical obstruction to diffusion. Cell-generated forces and matrix deformation (i.e., densification and fiber alignment) were not found to significantly influence the release profiles. This knowledge is expected to improve fibrin integration in tissue engineering and drug delivery applications by enabling predictions and ways to modulate the release profiles of various biomolecules.

Indexed as

Drug Delivery SystemsAnimalsCell SurvivalDextransEndothelial CellsExtracellular MatrixFibrinFluorescein-5-isothiocyanateHeterocyclic Compounds, 4 or More RingsHumansHuman Umbilical Vein Endothelial CellsHydrogelsMiceModels, TheoreticalNIH 3T3 CellsRegenerationblebbistatinDextransFibrinFluorescein-5-isothiocyanatefluorescein isothiocyanate dextranHeterocyclic Compounds, 4 or More RingsHydrogelscell-matrix interactioncontrolled releasedrug deliveryextracellular matrixfibrinFITC-dextran (FD)hydrogelsregenerative medicinetissue engineeringtraction force

Identifiers

PMID33672379
PMCPMC7926394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.